Frazier Management LLC’s Krystal Biotech Inc Position
Does Frazier Management LLC own Krystal Biotech Inc (KRYS)? Not currently — the last reported position was 771.3K shares worth $54M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$54M
Q4 2021
Shares
771.3K
% of Portfolio
+4.15%
Quarters Held
13
position exited
Position History KRYS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2021 | 771.3K | $54M | +4.15% |
| Q3 2021 | 771.3K | $40M | +3.22% |
| Q2 2021 | 787.9K | $54M | +4.94% |
| Q1 2021 | 895.0K | $69M | +5.53% |
| Q4 2020 | 895.0K | $54M | +4.14% |
| Q3 2020 | 895.0K | $39M | +3.46% |
| Q2 2020 | 895.0K | $37M | +3.26% |
| Q1 2020 | 895.0K | $39M | +4.39% |
| Q4 2019 | 895.0K | $50M | +8.31% |
| Q3 2019 | 895.0K | $31M | +9.72% |
| Q2 2019 | 895.0K | $36M | +9.24% |
| Q1 2019 | 875.0K | $29M | +6.93% |
| Q4 2018 | 875.0K | $18M | +4.69% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of KRYS.